• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Alcon Inc. (NYSE: ACL)

Alcon, Inc. is the world's leading eye care company, with sales of approximately $4.9 billion in 2006. Alcon, which has been dedicated to the ophthalmic industry for 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. *

 

	Start	2005-10-19 existent
	Group	Novartis (Group)
	Industry	ophthalmic
	Region	Hünenberg ZG
	Country	Switzerland
	Street	69 Bösch
	City	6331 Hünenberg ZG
	Tel	+41-785-8888
		Address record changed: 2018-07-24
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	4,896,600,000 (sales, consolidated (2006) 2006-12-31)
	Profit	1,348,100,000 (2006-12-31)
	Cash	1,489,200,000 (2006-12-31)
		* Document for �About Section�:
		Record changed: 2017-10-07

Advertisement

More documents for Novartis (Group)

• [1] Dyno Therapeutics, Inc.. (5/11/20). "Press Release: Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology". Cambridge, MA....
• [2] Syncona Ltd.. (4/30/20). "Press Release: Danny Bar-Zohar Joins Syncona as Partner"....
• [3] Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent....
• [4] Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris....
• [5] Novartis AG. (2/17/20). "Press Release: Novartis Receives EC Approval for Beovu, a Next-generation anti-VEGF Treatment for wet AMD, a Leading Cause of Blindness Worldwide". Basel....
• [6] BenchSci. (2/4/20). "Press Release: BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend". Toronto....
• [7] Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden....
• [8] Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris....
• [9] Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel....
• [10] Flagship Pioneering. (11/12/19). "Press Release: Flagship Pioneering Appoints Prakash Raman, Ph.D. as Senior Partner and Chief Business Development Officer". Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.